unknown
Stage
2
Investors
About
ARMO Biosciences develops next-generation cancer immunotherapies by engineering cytokine and immune cell therapies to enhance efficacy and safety in treating solid tumors.
Explore ARMO Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.